Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT04295148
Recruiting Not applicable

SEQUAR SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction

NCT04295148 · tracked via the Priya Life Science Sweden tracker
Sponsor
Karolinska Institutet
Phase
Not applicable
Started
2020-02-10
Last updated
2025-09-18

Condition(s) studied

Anterior Cruciate Ligament InjuriesAnterior Cruciate Ligament RuptureAnterior Cruciate Ligament Tear

Investigational drug(s) / intervention(s)

ACL Reconstruction with Semitendinosus graftACL Reconstruction with Quadriceps tendon-bone graft

ACL Reconstruction with Semitendinosus graft: Participants will undergo Anterior Cruciate Ligament Reconstruction with Semitendinosus graft

ACL Reconstruction with Quadriceps tendon-bone graft: Participants will undergo Anterior Cruciate Ligament Reconstruction with Quadriceps tendon-bone graft

Study summary

Randomized control trial comparing two different Anterior Cruciate Ligament (ACL) grafts in Anterior Cruciate Ligament Reconstruction: the semitendinosus hamstrings graft and the quadriceps graft. Capio Artro Clinic (Stockholm) has vast experience in ACL surgery using both semitendinosus and quadriceps grafts.

Eligibility

Sex
ALL
Min age
16 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Pre-injury Tegner Activity Scale≥7 * Intended return to sports to prior sport and Tegner Activity Scale Level * Time between injury and inclusion not more than 6 months * MR verified ACL rupture Exclusion Criteria: * Previous knee injury with symptoms before ACL injury * Neurological disease, inflammatory disease, connective tissue disease or balance disorder * Previous lower limb fracture or surgery * Laxity in the medial collateral ligament (MCL) and lateral collateral ligament (LCL) \> grade 1 * PCL rupture or Multiligament knee injury (MLKI) * Radiographic sign of osteoarthritis (OA) * Previous knee surgery or ligament injury in contralateral knee * Beighton score ≥ 5

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Capio Artro Clinic AB Stockholm Stockholm County Recruiting

More Karolinska Institutet trials in Sweden

Sensory Neurography and S2PD, a Test-Retest Study Active, not recruiting
Diagnostic and Prognostic Salivary Biomarkers in Chronic Muscle Pain Active, not recruiting
Brain Connectivity Marker for Alzheimer's Disease Recruiting
Feasibility, Acceptability, and Preliminary Effects of ISTDP for Personality Disorders in a Specialized Psychiatric Clinic Enrolling by invitation
Health-related Quality of Life in Chiari Malformation Type 1 - A National Cross-Sectional Patient Survey Enrolling by invitation

Other trials for the same condition

Operation Korsband Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04295148 on ClinicalTrials.gov ↗ ← All trials in Sweden